HopeStage
Back to all studies
CompletedNCT00320489

Long-acting olanzapine injections or tablets for schizophrenia

About this titleRead the official source — NCT00320489
Medication studyAges 18–65Multiple countries
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
Escondido and 48 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateApril 2006
Recruitment status
Completed
Enrollment listed in the registry
524
Sponsor
Eli Lilly and Company
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States, France, Canada, ...
Age range
From 18 Years to 65 Years
Official registry ID
NCT00320489
Official title
Show the full official title

A Randomized, Open-label Study Comparing the Effects of Olanzapine Pamoate Depot With Oral Olanzapine on Treatment Outcomes in Outpatients With Schizophrenia

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Escondido, United States · National City, United States · Orange, United States

46 more locations
  • San Diego, United States
  • Washington D.C., United States
  • Honolulu, United States
  • Chicago, United States
  • Cedarhurst, United States
  • Staten Island, United States
  • Canton, United States
  • Allentown, United States
  • Philadelphia, United States
  • West Chester, United States
  • Banfield, Argentina
  • Buenos Aires, Argentina
  • Mendoza, Argentina
  • Pelotas, Brazil
  • Rio de Janeiro, Brazil
  • São Paulo, Brazil
  • Calgary, Canada
  • Winnipeg, Canada
  • Burlington, Canada
  • Chatham, Canada
  • Greater Sudbury, Canada
  • Montreal, Canada
  • Dijon, France
  • Dole, France
  • La Seyne-sur-Mer, France
  • Limoges, France
  • Strasbourg, France
  • Toulon, France
  • Chaïdári, Greece
  • Haidari, Athens, Greece
  • Thessaloniki, Greece
  • Tripoli, Greece
  • Lisbon, Portugal
  • Cabo Rojo, Puerto Rico
  • Caguas, Puerto Rico
  • Mayagüez, Puerto Rico
  • Rio Piedras, Puerto Rico
  • Bucharest, Romania
  • Iași, Romania
  • Târgu Mureş, Romania
  • Bratislava, Slovakia
  • Alzira, Spain
  • Barcelona, Spain
  • Hua-Lian County, Taiwan
  • Taipei, Taiwan
  • Taoyuan City, Taiwan

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Eli Lilly and Company.

Did this study involve medication?

Yes. The study involved medication, including olanzapine and olanzapine pamoate depot.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies